Event-Driven Stocks

SUPERNUS PHARMACEUTICALS, INC.

Other · SEC filings ↗ · Compare ⊕

Signs● 5 good● 2 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$719.0M$661.8M$607.5M$667.2M$579.8M$520.4M
Operating income−$62.3M$81.7M−$5.3M$46.1M$86.0M$173.7M
Net income−$38.5M$73.9M$1.3M$60.7M$53.4M$127.0M
Total assets$1.45B$1.37B$1.28B$1.70B$1.69B$1.50B
Total liabilities$390.9M$332.3M$356.2M$816.3M$873.3M$759.2M
Equity$1.06B$1.04B$921.5M$886.2M$815.9M$744.9M
EPS (diluted)$-0.68$1.32$0.02$1.04$0.98$2.36
Shares out.55.8M55.7M54.4M53.4M52.9M52.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−8.7%
Net margin
−5.4%
Return on equity
−3.6%
Return on assets
−2.7%
Return on capital (ROCE)
−5.6%
Liabilities / assets
26.9%
Debt / equity
0.37×
Book value / share
$19.02
Revenue growth (YoY)
8.6%
Net income growth (YoY)
−152.2%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
5.11safe
Accruals / assets
−5.9%clean
Beneish M-Score
-2.54normal
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
57
/ 100
Profitability 0Growth 50Catalyst 33Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 2 warning● 5 good
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)